FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+6.11%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$40.7M
AUM Growth
+$40.7M
(-30%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-37.82%
Top 10 Holdings %
Top 10 Hldgs %
57.36%
Holding
159
New
20
Increased
12
Reduced
19
Closed
42
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$3.53M |
| 2 |
Amgen
AMGN
|
$2.08M |
| 3 |
iShares Biotechnology ETF
IBB
|
$1.87M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$1.79M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$1.51M |
Top Sells
| 1 |
Abbott
ABT
|
$5.39M |
| 2 |
Foot Locker
FL
|
$2.12M |
| 3 |
General Mills
GIS
|
$1.97M |
| 4 |
lululemon athletica
LULU
|
$1.38M |
| 5 |
United Therapeutics
UTHR
|
$1.32M |
Sector Composition
| 1 | Healthcare | 53.53% |
| 2 | Consumer Staples | 24.42% |
| 3 | Consumer Discretionary | 3.84% |
| 4 | Communication Services | 1.93% |
| 5 | Materials | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.89M | 6.69% |
41,500
+37,679
| +986% | +$3.53M |
|
|
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.36M | 5.79% |
33,557
+7,728
| +30% | +$775K |
|
|
3
General Mills
GIS
$26.4B
| $2.82M | 4.86% |
50,896
-35,501
| -41% | -$1.97M |
|
|
4
Abbott
ABT
$231B
| $2.43M | 4.19% |
50,070
-110,900
| -69% | -$5.39M |
|
|
PTLA
5
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.31M | 3.98% |
41,187
+31,882
| +343% | +$1.79M |
|
|
6
iShares Biotechnology ETF
IBB
$5.6B
| $2.09M | 3.6% |
6,747
+6,042
| +857% | +$1.87M |
|
|
7
Amgen
AMGN
$155B
| $2.08M | 3.58% |
+12,082
| New | +$2.08M |
|
|
TSRO
8
DELISTED
TESARO, Inc.
TSRO
| $1.51M | 2.6% |
+10,805
| New | +$1.51M |
|
9
Mondelez International
MDLZ
$79.5B
| $1.44M | 2.48% |
33,354
-7,550
| -18% | -$326K |
|
10
Alibaba
BABA
$322B
| $1.4M | 2.4% |
9,900
+45
| +0.5% | +$6.34K |
|
11
Clorox
CLX
$14.5B
| $1.28M | 2.21% |
+9,623
| New | +$1.28M |
|
12
Kellanova
K
$27.6B
| $1.25M | 2.15% |
17,978
-17,046
| -49% | -$1.18M |
|
|
OTIC
13
DELISTED
Otonomy, Inc.
OTIC
| $1.1M | 1.9% |
58,407
-25,340
| -30% | -$478K |
|
14
Colgate-Palmolive
CL
$67.9B
| $1.02M | 1.75% |
+13,747
| New | +$1.02M |
|
15
DaVita
DVA
$9.85B
| $948K | 1.63% |
14,639
+12,939
| +761% | +$838K |
|
16
AB InBev
BUD
$122B
| $796K | 1.37% |
7,209
+671
| +10% | +$74.1K |
|
|
SAGE
17
DELISTED
Sage Therapeutics
SAGE
| $783K | 1.35% |
9,830
-9,383
| -49% | -$747K |
|
|
POT
18
DELISTED
Potash Corp Of Saskatchewan
POT
| $653K | 1.12% |
40,080
-60,000
| -60% | -$978K |
|
|
CELG
19
DELISTED
Celgene Corp
CELG
| $649K | 1.12% |
+5,000
| New | +$649K |
|
|
MDCO
20
DELISTED
Medicines Co
MDCO
| $644K | 1.11% |
16,931
-7,168
| -30% | -$273K |
|
21
Sarepta Therapeutics
SRPT
$1.78B
| $539K | 0.93% |
15,993
+9,617
| +151% | +$324K |
|
22
Walt Disney
DIS
$213B
| $531K | 0.91% |
5,000
-3,449
| -41% | -$366K |
|
|
CASC
23
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $473K | 0.81% |
127,429
-16,000
| -11% | -$59.4K |
|
|
MNK
24
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $448K | 0.77% |
+10,000
| New | +$448K |
|
25
SCYNEXIS
SCYX
$34.9M
| $432K | 0.74% |
241,236
+57,305
| +31% | +$103K |
|